Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Vijaypd Ceutical Ltd. IPO is a fixed price issue of ₹19.25 crores. The issue is entirely a fresh issue of 0.55 crore shares of ₹19.25 crore.
Vijaypd Ceutical IPO bidding started from Sep 29, 2025 and ended on Oct 1, 2025. The allotment for Vijaypd Ceutical IPO was finalized on Oct 3, 2025. The shares got listed on NSE SME on Oct 7, 2025.
Vijaypd Ceutical IPO price is ₹35.00 per share . The lot size for an application is 4,000. The minimum amount of investment required by an individual investor (retail) is ₹2,80,000.00 (8,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (12,000 shares), amounting to ₹4,20,000.
Smart Horizon Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Shreni Shares Ltd..
Refer to Vijaypd Ceutical IPO DRHP for detailed Information.
| IPO Date | September 29, 2025 to October 1, 2025 |
| Listing Date | October 7, 2025 |
| Face Value | ₹10 per share |
| Issue Price Final | ₹35 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 55,00,000 shares (aggregating up to ₹19.25 Cr) |
| Reserved for Market Maker | 2,84,000 shares Shreni Shares Ltd. (aggregating up to ₹0.9940 Cr) |
| Net Offered to Public | 52,16,000 shares (aggregating up to ₹18.26 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,40,28,686 shares |
| Share Holding Post Issue | 1,95,28,686 shares |
Vijaypd Ceutical IPO offers total 55,00,000 shares. Out of which 26,08,000 (47.42%) allocated to NII 26,08,000 (47.42%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 2,84,000 (5.16%) |
| NII (HNI) Shares Offered | 26,08,000 (47.42%) |
| Retail Shares Offered | 26,08,000 (47.42%) |
| Total Shares Offered | 55,00,000 (100.00%) |
Vijaypd Ceutical IPO opens on September 29, 2025, and closes on October 1, 2025.
| IPO Open Date | Mon, Sep 29, 2025 |
| IPO Close Date | Wed, Oct 1, 2025 |
| Tentative Allotment | Fri, Oct 3, 2025 |
| Initiation of Refunds | Mon, Oct 6, 2025 |
| Credit of Shares to Demat | Mon, Oct 6, 2025 |
| Tentative Listing Date | Tue, Oct 7, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Oct 1, 2025 |
Investors can bid for a minimum of 8,000 shares and in multiples of 4,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 8,000 | ₹2,80,000 |
| Individual investors (Retail) (Max) | 2 | 8,000 | ₹2,80,000 |
| HNI (Min) | 3 | 12,000 | ₹4,20,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.
The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.
The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.
As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.
The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.
This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.
The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.
Competitive Strength:
Vijaypd Ceutical Ltd.'s revenue increased by 98% and profit after tax (PAT) rose by 191% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 57.15 | 33.27 | 32.87 |
| Total Income | 107.59 | 54.34 | 50.59 |
| Profit After Tax | 4.80 | 1.65 | 0.18 |
| EBITDA | 8.59 | 4.87 | 1.32 |
| NET Worth | 32.17 | 1.00 | 4.93 |
| Reserves and Surplus | 18.14 | ||
| Total Borrowing | 21.77 | 30.04 | 25.56 |
| Amount in ₹ Crore | |||
| KPI | Values |
|---|---|
| ROE | 28.91% |
| ROCE | 17.30% |
| Debt/Equity | 0.68 |
| RoNW | 14.91% |
| PAT Margin | 4.49% |
| EBITDA Margin | 8.04% |
The Company Vijaypd Ceutical IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra | 10.83 |
| 2 | Repayment/prepayment of all or certain of the borrowings availed of by the Company | 5.10 |
| 3 | General corporate purposes | 0.74 |
[Dilip Davda] VCL is engaged in the business of distribution and supply of healthcare, personal care and other FMCG products. While marking growth for the reported period in its earnings, boosted performance for FY25 is a bit surprising. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed/cash surplus investors may park moderate funds for long term. Read detail review...
| Listing Date | October 7, 2025 |
| BSE Script Code | |
| NSE Symbol | VIJAYPD |
| ISIN | INE0WL901019 |
| Final Issue Price | ₹35 per share |
| NSE Listing Group | ST (Trade to Trade) |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹35.00 |
| Open | ₹35.00 |
| Low | ₹35.00 |
| High | ₹36.75 |
| Last Trade | ₹35.90 |
Vijaypd Ceutical Ltd.
A/1, 1st Floor
Devraj Premises
CHSL, Goregaon West
Mumbai, Maharashtra, 400062
Phone: +91 9820917040
Email: investors@vijaypdceutical.com
Website: https://www.vijaypdceutical.com/
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: vcl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Vijaypd Ceutical IPO is a SME IPO of 55,00,000 equity shares of the face value of ₹10 aggregating up to ₹19.25 Crores. The issue is priced at ₹35 per share. The minimum order quantity is 4000.
The IPO opens on September 29, 2025, and closes on October 1, 2025.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Vijaypd Ceutical IPO using UPI as a payment gateway. Zerodha customers can apply in Vijaypd Ceutical IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Vijaypd Ceutical IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Vijaypd Ceutical IPO opens on September 29, 2025 and closes on October 1, 2025.
Vijaypd Ceutical IPO lot size is 4000, and the minimum amount required for application is ₹2,80,000, with 2 lots being the minimum application size.
You can apply in Vijaypd Ceutical IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Vijaypd Ceutical IPO will be done on Friday, October 3, 2025, and the allotted shares will be credited to your demat account by Monday, October 6, 2025. Check the Vijaypd Ceutical IPO allotment status.
The Vijaypd Ceutical IPO listing date is on Tuesday, October 7, 2025.
Useful Articles
DRHP